Page last updated: 2024-09-04

olmesartan and aldosterone

olmesartan has been researched along with aldosterone in 17 studies

Compound Research Comparison

Studies
(olmesartan)
Trials
(olmesartan)
Recent Studies (post-2010)
(olmesartan)
Studies
(aldosterone)
Trials
(aldosterone)
Recent Studies (post-2010) (aldosterone)
84118555425,3331,5174,169

Protein Interaction Comparison

ProteinTaxonomyolmesartan (IC50)aldosterone (IC50)
Mineralocorticoid receptor Homo sapiens (human)0.0048
Mineralocorticoid receptorRattus norvegicus (Norway rat)0.043

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (11.76)29.6817
2010's14 (82.35)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Abe, Y; Baba, R; Fan, YY; Fujita, M; Hosomi, N; Kimura, S; Kohno, M; Miyatake, A; Nagai, Y; Nishiyama, A; Sun, GP1
Agata, J; Hyakkoku, M; Sasaki, H; Shimamoto, K; Shinshi, Y; Taniguchi, S; Ura, N; Yoshida, H1
Fujii, M; Horie, M; Kawahara, C; Nishiyama, K; Tsutamoto, T; Yamaji, M; Yamamoto, T1
Eguchi, K; Ishikawa, J; Kario, K; Matsui, Y; O'Rourke, MF; Shimada, K1
Ando, K; Fujita, M; Fujita, T; Kawarasaki, C; Kawarazaki, H; Matsui, H; Muraoka, K; Nagae, A1
Abe, M; Maruyama, N; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M1
Hata, M; Sezai, A; Shiono, M; Soma, M; Unosawa, S; Wakui, S; Yoshitake, I1
Conte, D; Nishiyama, A; Ortiz, RM; Viscarra, J1
Deguchi, K; Hitomi, H; Kitada, K; Kobori, H; Lei, B; Masaki, T; Minamino, T; Mori, H; Nakano, D; Nishiyama, A1
Hamada, J; Kobara, M; Nakata, T; Noda, K; Shiraishi, T; Tanaka, T; Toba, H; Wang, J; Yoshifuji, Y1
Araki, N; Ishigami, T; Kakizoe, Y; Kitamura, K; Maeda, E; Minegishi, S; Tamura, K; Umemura, M; Umemura, S; Ushio-Yamana, H1
Iki, Y; Ito, R; Ito, S; Kogure, N; Kudo, M; Matsuda, K; Nezu, M; Rainey, WE; Saito-Hakoda, A; Saito-Ito, T; Sato, I; Satoh, F; Shimada, H; Shimizu, K; Sugawara, A; Sugawara, K; Uruno, A; Yokoyama, A; Yoshikawa, T1
Bin, J; Cao, S; Chen, B; Fu, Y; Huang, Q; Huang, X; Kitakaze, M; Liao, Y; Lu, D; Xu, D; Zhang, J1
Abe, M; Oikawa, O; Okada, K; Soma, M1
Arimoto, M; Hata, H; Osaka, S; Sakino, H; Sezai, A; Shiono, M; Yaoita, H1
Hirooka, Y; Nishihara, M; Takesue, K1
Ceolotto, G; Cesari, M; Maiolino, G; Rossi, GP; Rossitto, G; Seccia, TM1

Trials

5 trial(s) available for olmesartan and aldosterone

ArticleYear
Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:2

    Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Middle Aged; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Tetrazoles

2010
Association between aldosterone induced by antihypertensive medication and arterial stiffness reduction: the J-CORE study.
    Atherosclerosis, 2011, Volume: 215, Issue:1

    Topics: Aged; Aldosterone; Antihypertensive Agents; Aorta; Azetidinecarboxylic Acid; Blood Flow Velocity; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Imidazoles; Male; Pulsatile Flow; Tetrazoles; Vascular Resistance

2011
Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:8

    Topics: Aged; Albuminuria; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles

2011
Effects of olmesartan on the renin-angiotensin-aldosterone system for patients with essential hypertension after cardiac surgery--investigation using a candesartan change-over study.
    Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2011, Volume: 17, Issue:5

    Topics: Aged; Aldosterone; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arteries; Benzimidazoles; Biphenyl Compounds; Cardiac Surgical Procedures; Compliance; Drug Substitution; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Prospective Studies; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome

2011
Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study).
    Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2016, Jun-20, Volume: 22, Issue:3

    Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Blood Pressure; Cardiac Surgical Procedures; Drug Substitution; Essential Hypertension; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Oxadiazoles; Prospective Studies; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Remodeling

2016

Other Studies

12 other study(ies) available for olmesartan and aldosterone

ArticleYear
Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2006, Volume: 29, Issue:3

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Creatine; Hypertension; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Male; Nephrectomy; Organ Size; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta

2006
Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2006, Volume: 29, Issue:11

    Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Gene Expression; Imidazoles; Male; Myocardium; Nitrates; Nitrites; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Tetrazoles; Ventricular Remodeling

2006
Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
    American journal of physiology. Renal physiology, 2011, Volume: 300, Issue:6

    Topics: Acute Kidney Injury; Aldosterone; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Eplerenone; Hypertension; Imidazoles; Immunohistochemistry; Kidney; Male; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Sodium Chloride; Spironolactone; Tetrazoles

2011
Chronic angiotensin receptor blockade suppresses intracardiac angiotensin II in angiotensin II-infused rats.
    Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:12

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Heart; Imidazoles; Kidney; Male; Myocardium; Rats; Rats, Sprague-Dawley; Tetrazoles

2011
Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice.
    American journal of hypertension, 2012, Volume: 25, Issue:3

    Topics: Actins; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cellular Senescence; Eplerenone; Genes, p16; Genes, p53; Hydralazine; Hypertension; Imidazoles; Kidney; Mice; Mice, Inbred C57BL; p21-Activated Kinases; Sirtuin 1; Sodium Chloride; Spironolactone; Tetrazoles

2012
Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Journal of cardiovascular pharmacology, 2012, Volume: 60, Issue:2

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Heart Failure; Hemodynamics; Imidazoles; Lipid Peroxidation; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Spironolactone; Tetrazoles; Ventricular Function, Left

2012
Renin angiotensin antagonists normalize aberrant activation of epithelial sodium channels in sodium-sensitive hypertension.
    Nephron. Experimental nephrology, 2012, Volume: 122, Issue:3-4

    Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Down-Regulation; Epithelial Sodium Channels; Eplerenone; Hypertension; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Perindopril; Renin; Sodium; Sodium Chloride, Dietary; Spironolactone; Tetrazoles

2012
Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells.
    Molecular and cellular endocrinology, 2014, Mar-05, Volume: 383, Issue:1-2

    Topics: Adrenal Glands; Aldosterone; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cytochrome P-450 CYP11B2; Gene Expression Regulation; Genes, Reporter; Humans; Imidazoles; Luciferases; Nuclear Receptor Subfamily 4, Group A, Member 1; Promoter Regions, Genetic; Protein Kinase Inhibitors; Receptors, Angiotensin; Sulfonamides; Telmisartan; Tetrazoles; Transcription, Genetic

2014
Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53.
    British journal of pharmacology, 2014, Volume: 171, Issue:15

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Cells, Cultured; Fibroblasts; Growth Differentiation Factor 15; Heart Rupture; Hypoxia; Imidazoles; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Peroxidase; Tetrazoles; Tumor Suppressor Protein p53

2014
Urinary angiotensin-converting enzyme 2 increases in diabetic nephropathy by angiotensin II type 1 receptor blocker olmesartan.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2015, Volume: 16, Issue:1

    Topics: Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Heart Rate; Humans; Imidazoles; Kidney Function Tests; Male; Middle Aged; Peptidyl-Dipeptidase A; Prospective Studies; Renin; Tetrazoles

2015
Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2019, Volume: 41, Issue:3

    Topics: Albuminuria; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Combined Modality Therapy; Heart; Hypertension; Imidazoles; Kidney; Male; Mice; Mice, Inbred ICR; Nephrectomy; Organ Size; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sympathectomy; Sympathetic Nervous System; Tetrazoles

2019
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
    The Journal of clinical endocrinology and metabolism, 2020, 06-01, Volume: 105, Issue:6

    Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Canrenone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Imidazoles; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prognosis; Prospective Studies; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles

2020